Rationale and design of the Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) trial

Author： Odili Augustine N.   Richart Tom   Thijs Lutgarde   Kingue Samuel   Boombhi Hilaire J.   Lemogoum Daniel   Kaptue Joseph   Kamdem Marius K.   Mipinda Jean-Bruno   Omotoso Babatunde A.   Kolo Philip M.   Aderibigbe Ademola   Ulasi Ifeoma I.   Anisiuba Benedict C.   Ijoma Chinwuba K.   Ba Serigne A.   Ndiaye Mouhamadou B.   Staessen Jan A.   M'Buyamba-Kabangu Jean-René    

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.20, Iss.5, 2011-10, pp. : 256-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients

By Wu San-Chiang   Liu Chun-Peng   Chiang Hung-Ting   Lin Shoa-Lin  

Heart and Vessels, Vol. 19, Iss. 1, 2004-01 ,pp. : 13-18

Springer Publishing Company

Access to resources Recommend Favorite

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design

By MANN JESSICA   JULIUS STEVO  

Blood Pressure, Vol. 7, Iss. 3, 1998-08 ,pp. : 176-183

Informa Healthcare

Access to resources Recommend Favorite

Management of older hypertensive patients

By Hedner Thomas   Kjeldsen Sverre   Oparil Susanne   Narkiewics Krzysztof  

Blood Pressure, Vol. 17, Iss. 4, 2008-01 ,pp. : 184-185

Informa Healthcare

Access to resources Recommend Favorite

Home versus office blood pressure MEasurements: reduction of unnecessary treatment study: rationale and study design of the HOMERUS trial

By Verberk W. J.   Kroon A. A.   Kessels A. G. H.   Dirksen C.   Nelemans P. J.   Lenders J. W. M.   Thien Th. A. B. M.   Montfrans G. A. van   Smit A. J.   Leeuw P. W. de  

Blood Pressure, Vol. 12, Iss. 5-6, 2003-11 ,pp. : 326-333

Informa Healthcare

Access to resources Recommend Favorite

Rationale, Design and Baseline Data of a Randomized, Double-Blind, Controlled Trial Comparing Two Antithrombotic Regimens (a Fixed-Dose Combination of Extended-Release Dipyridamole plus ASA with Clopidogrel) and Telmisartan versus Placebo in Patients with Strokes: The Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS)

By  

Cerebrovascular Diseases, Vol. 23, Iss. 5-6, 2007-02 ,pp. : 368-380

Karger

Access to resources Recommend Favorite